Literature DB >> 11462022

Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

I Tsunoda1, Y Wada, J E Libbey, T S Cannon, F G Whitby, R S Fujinami.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) is divided into two subgroups based on neurovirulence. During the acute phase, DA virus infects cells in the gray matter of the central nervous system (CNS). Throughout the chronic phase, DA virus infects glial cells in the white matter, causing demyelinating disease. Although GDVII virus also infects neurons in the gray matter, infected mice developed a severe polioencephalomyelitis, and no virus is detected in the white matter or other areas in the CNS in rare survivors. Several sequence differences between the two viruses are located in VP2 puff B and VP1 loop II, which are located near each other, close to the proposed receptor binding site. We constructed a DA virus mutant, DApBL2M, which has the VP1 loop II of GDVII virus and a mutation at position 171 in VP2 puff B. While DApBL2M virus replicated less efficiently than DA virus during the acute phase, DApBL2M-induced acute polioencephalitis was comparable to that in DA virus infection. Interestingly, during the chronic phase, DApBL2M caused prolonged gray matter disease in the brain without white matter involvement in the spinal cord. This is opposite what is observed during wild-type DA virus infection. Our study is the first to demonstrate that conformational differences via interaction of VP2 puff B and VP1 loop II between GDVII and DA viruses can play an important role in making the transition of infection from the gray matter in the brain to the spinal cord white matter during TMEV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462022      PMCID: PMC114985          DOI: 10.1128/JVI.75.16.7494-7505.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Neutralization of Theiler's virus.

Authors:  S GARD
Journal:  Acta Pathol Microbiol Scand       Date:  1955

2.  The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  J P Simas; J K Fazakerley
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

3.  Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus.

Authors:  K R Oliver; P Brennan; J K Fazakerley
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Authors:  Y Wada; M L Pierce; R S Fujinami
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  Follicular dendritic cells and human immunodeficiency virus infectivity.

Authors:  S L Heath; J G Tew; J G Tew; A K Szakal; G F Burton
Journal:  Nature       Date:  1995-10-26       Impact factor: 49.962

6.  Three-dimensional structure of Theiler virus.

Authors:  R A Grant; D J Filman; R S Fujinami; J P Icenogle; J M Hogle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus.

Authors:  A Inoue; Y K Choe; B S Kim
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.

Authors:  Q Li; A G Yafal; Y M Lee; J Hogle; M Chow
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease.

Authors:  N D Tolley; I Tsunoda; R S Fujinami
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus.

Authors:  A Zurbriggen; J M Hogle; R S Fujinami
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  32 in total

1.  Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

2.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

3.  Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Mikako Kobayashi-Warren; Robert S Fujinami
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Emily Jane Terry; Robert S Fujinami
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  Innate but not adaptive immune responses contribute to behavioral seizures following viral infection.

Authors:  Nikki J Kirkman; Jane E Libbey; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

6.  Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

7.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

8.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

9.  Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.

Authors:  Fumitaka Sato; Nicholas E Martinez; Maira Shahid; John W Rose; Noel G Carlson; Ikuo Tsunoda
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

10.  Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2008-12-26       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.